ABVC BioPharma Inc Q1 2025 Earnings Narrowed Loss Highlights Continued Pipeline Progress MGYR Q4 2025 Earnings EPS of 040 Reported Stock Unchanged NXE Q1 2026 Earnings WiderthanExpected Loss Amid Strategic Progress in Uranium Development RILYT Q1 2024 Earnings Negative EPS Highlights Challenges for Senior Notes Holders CCID Q1 2026 Earnings Preferred Shares Rise Despite Significant EPS Miss HLX Q1 2026 Earnings EPS Misses Estimates Amid Challenging Conditions